Digital Therapeutics Market Size, Share, and Analysis, By Type (Devices, Software & Services), By Application (Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, Others), By End User (Patients, Providers, Payers, Employers, Others) and Regional Forecasts, 2022-2032

September 2023 | 401 pages | ID: D3A002B3982DEN
Fatpos Global

Abstracts

Digital Therapeutics Market Size, Share, and Analysis, By Type (Devices, Software & Services), By Application (Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, Others), By End User (Patients, Providers, Payers, Employers, Others) and Regional Forecasts, 2022-2032

PRODUCT OVERVIEW

Digital Therapeutics Market size was USD 3.68 billion in 2021 and is projected t%li%grow from USD 5.8 billion in 2023 t%li%USD 47.2 billion by 2032, exhibiting a CAGR of 26.1% during the forecast period.

Digital Therapeutics (DTx) is software-driven, factual therapeutic intervention that prevent, treat, or manage medical conditions. These patient-facing software programs come with a demonstrated clinical advantage that supports the management, treatment, and prevention of diseases. The term 'Digital Health' refers t%li%any platforms and technology that offer digital solutions t%li%enhance the delivery of healthcare. Some common examples of this include telehealth, smart gadgets, mobile health, sensors, wearable technology, etc.

MARKET HIGHLIGHTS

Digital Therapeutics market is expected t%li%reach USD 47.2 billion, growing at a CAGR of 26.1% during the forecast period owing t%li%the increasing cases of preventable chronic diseases, the need t%li%reduce healthcare expenditures, the growth of venture capital, and the advantages in digital therapies. Moreover, digital therapies can increase marginalized populations' access t%li%care and let medical professionals manage chronic illnesses more effectively. These factors are projected t%li%fuel the global Digital Therapeutics Market over the forecast period.

Digital Therapeutics Market Segments:

• Type
• Devices
• Software & Services
• Application
• Diabetes
• Obesity
• CVD
• Respiratory Diseases
• Smoking Cessation
• CNS Diseases
• Others
• End User
• Patients
• Providers
• Payers
• Employers
• Others

MARKET DYNAMICS

Growth Drivers

Increasing Need t%li%Control Healthcare Prices is Expected t%li%Boost the Market Growth

Growing Digitalization & The Emergence of Smart Medical Devices are Expected t%li%Boost the Market Growth

Restraint

Rising Number of Issues Associated with Cybersecurity May Restrain the Market Growth

Key Players

• AmerisourceBergen
• ResMed
• Teladoc Health Inc.
• Fitbit LLC
• Omada Health Inc.
• Pear Therapeutics Inc.
• GAIA AG
• BigHealth
• Welldoc Inc.
• DarioHealth Corp.
• Akili Interactive Labs Inc.
• HYGIEIA
• Canary Health
• 2Morrow Inc.
• Limbix Health Inc.
• Other Prominent Players

(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons t%li%Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight int%li%the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
• 3-month post-sales analyst support.

Contents

1 EXECUTIVE SUMMARY

1.1. Regional Market Share
1.2. Business Trends
1.3. Digital Therapeutics Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot

2 RESEARCH METHODOLOGY

2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
  2.5.1. Paid Sources
  2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation

3 MARKET CHARACTERISTICS

3.1. Market Definition
3.2. Digital Therapeutics Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4 DIGITAL THERAPEUTICS MARKET – INDUSTRY INSIGHTS

4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5 MACROECONOMIC INDICATORS


6 RECENT DEVELOPMENTS


7 MARKET DYNAMICS

7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends

8 MARKET ANALYSIS

8.1. Porters Five Forces
8.2. PEST Analysis
  8.2.1. Political
  8.2.2. Economic
  8.2.3. Social
  8.2.4. Technological

9 DIGITAL THERAPEUTICS MARKET

9.1. Overview
9.2. Historical Analysis (2016-2021)
  9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

10 DIGITAL THERAPEUTICS MARKET SIZE & FORECAST 2022A-2032F

10.1. Overview
10.2. Key Findings
10.3. Market Segmentation
  10.3.1. By Type
    10.3.1.1. Devices
      10.3.1.1.1. By Value (USD Million) 2022-2032F
      10.3.1.1.2. Market Share (%) 2022-2032F
      10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
    10.3.1.2. Software & Services
      10.3.1.2.1. By Value (USD Million) 2022-2032F
      10.3.1.2.2. Market Share (%) 2022-2032F
      10.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
  10.3.2. By Application
    10.3.2.1. Diabetes
      10.3.2.1.1. By Value (USD Million) 2022-2032F
      10.3.2.1.2. Market Share (%) 2022-2032F
      10.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
    10.3.2.2. Obesity
      10.3.2.2.1. By Value (USD Million) 2022-2032F
      10.3.2.2.2. Market Share (%) 2022-2032F
      10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
    10.3.2.3. CVD
      10.3.2.3.1. By Value (USD Million) 2022-2032F
      10.3.2.3.2. Market Share (%) 2022-2032F
      10.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
    10.3.2.4. Respiratory Diseases
      10.3.2.4.1. By Value (USD Million) 2022-2032F
      10.3.2.4.2. Market Share (%) 2022-2032F
      10.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
    10.3.2.5. Smoking Cessation
      10.3.2.5.1. By Value (USD Million) 2022-2032F
      10.3.2.5.2. Market Share (%) 2022-2032F
      10.3.2.5.3. Y-o-Y Growth (%) 2022-2032F
    10.3.2.6. CNS Diseases
      10.3.2.6.1. By Value (USD Million) 2022-2032F
      10.3.2.6.2. Market Share (%) 2022-2032F
      10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
    10.3.2.7. Others
      10.3.2.7.1. By Value (USD Million) 2022-2032F
      10.3.2.7.2. Market Share (%) 2022-2032F
      10.3.2.7.3. Y-o-Y Growth (%) 2022-2032F
  10.3.3. By End User
    10.3.3.1. Patients
      10.3.3.1.1. By Value (USD Million) 2022-2032F
      10.3.3.1.2. Market Share (%) 2022-2032F
      10.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
    10.3.3.2. Providers
      10.3.3.2.1. By Value (USD Million) 2022-2032F
      10.3.3.2.2. Market Share (%) 2022-2032F
      10.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
    10.3.3.3. Payers
      10.3.3.3.1. By Value (USD Million) 2022-2032F
      10.3.3.3.2. Market Share (%) 2022-2032F
      10.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
    10.3.3.4. Employers
      10.3.3.4.1. By Value (USD Million) 2022-2032F
      10.3.3.4.2. Market Share (%) 2022-2032F
      10.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
    10.3.3.5. Others
      10.3.3.5.1. By Value (USD Million) 2022-2032F
      10.3.3.5.2. Market Share (%) 2022-2032F
      10.3.3.5.3. Y-o-Y Growth (%) 2022-2032F

11 NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE & FORECAST 2022A-2032F

11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
  11.3.1. By Type
  11.3.2. By Application
  11.3.3. By End User
11.4. Country
  11.4.1. United States
  11.4.2. Canada

12 EUROPE DIGITAL THERAPEUTICS MARKET SIZE & FORECAST 2022A-2032F

12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
  12.3.1. By Type
  12.3.2. By Application
  12.3.3. By End User
12.4. Country
  12.4.1. Germany
  12.4.2. United Kingdom
  12.4.3. France
  12.4.4. Italy
  12.4.5. Spain
  12.4.6. Russia
  12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

13 ASIA DIGITAL THERAPEUTICS MARKET SIZE & FORECAST 2022A-2032F

13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
  13.3.1. By Type
  13.3.2. By Application
  13.3.3. By End User
13.4. Country
  13.4.1. India
  13.4.2. China
  13.4.3. South Korea
  13.4.4. Japan
  13.4.5. Rest of APAC

14 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET SIZE & FORECAST 2022A-2032F

14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
  14.3.1. By Type
  14.3.2. By Application
  14.3.3. By End User
14.4. Country
  14.4.1. Israel
  14.4.2. GCC
  14.4.3. North Africa
  14.4.4. South Africa
  14.4.5. Rest of Middle East and Africa

15 LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE & FORECAST 2022A-2032F

15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
  15.3.1. By Type
  15.3.2. By Application
  15.3.3. By End User
15.4. Country
  15.4.1. Mexico
  15.4.2. Brazil
  15.4.3. Rest of Latin America

16 COMPETITIVE LANDSCAPE

16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders

17 COMPANY PROFILES

17.1. AmerisourceBergen
  17.1.1. Company Overview
  17.1.2. Financial Overview
  17.1.3. Key Product; Analysis
  17.1.4. Company Assessment
    17.1.4.1. Product Portfolio
    17.1.4.2. Key Clients
    17.1.4.3. Market Share
    17.1.4.4. Recent News & Development (Last 3 Yrs.)
    17.1.4.5. Executive Team
17.2. ResMed
17.3. Teladoc Health Inc.
17.4. Fitbit LLC
17.5. Omada Health Inc.
17.6. Pear Therapeutics Inc.
17.7. GAIA AG
17.8. BigHealth
17.9. Welldoc Inc.
17.10. DarioHealth Corp.
17.11. Akili Interactive Labs Inc.
17.12. HYGIEIA
17.13. Canary Health
17.14. 2Morrow Inc.
17.15. Limbix Health Inc.
17.16. Other Prominent Players

18 APPENDIX


19 CONSULTANT RECOMMENDATION